The National Institute of Allergy and Infectious Diseases has awarded a five-year, $15 million grant to the San Diego Center for AIDS Research (CFAR) at UC San Diego, renewing support that extends back to an original establishing grant in 1994—the height of the AIDS epidemic.
Engineers have developed a tiny, ultra-low power chip that could be injected just under the surface of the skin for continuous, long-term alcohol monitoring. The chip is powered wirelessly by a wearable device such as a smartwatch or patch. The goal of this work is to develop a convenient, routine monitoring device for patients in substance abuse treatment programs.
Conflict, a death in the family, financial hardship and serious medical crises are all associated with accelerated physical aging. In a new study, researchers at the University of California San Diego School of Medicine found that such negative fateful life events — or FLEs — appear to also specifically accelerate aging in the brain.
The Lewy Body Dementia Association (LBDA), announced today that UC San Diego Health has been named a LBDA Research Centers of Excellence (RCOE), a partnership of 24 pre-eminent academic medical research centers across the United States. LBDA is a leading advocacy group dedicated to raising awareness and advancing research and treatment of Lewy body dementia (LBD).
Rising drug prices have gotten a lot of attention lately, but the actual cost of prescription medications is more than just the bill. Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego estimate that illness and death resulting from non-optimized medication therapy costs $528.4 billion annually, equivalent to 16 percent of total U.S. health care expenditures in 2016. The analysis is published March 26 by Annals of Pharmacotherapy.
The vast majority of genetic mutations associated with cancer occur in non-coding regions of the genome, yet it’s unclear how they may influence tumor development or growth. Researchers at University of California San Diego School of Medicine and Moores Cancer Center identified nearly 200 mutations in non-coding DNA that play a role in cancer. Each mutation could represent a new cancer drug target. The study is published April 2 in Nature Genetics.
Independent, March 10
The San Diego Union-Tribune, March 9
The New York Times, March 9
U.S. News & World Report, March 4
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
